1. Home
  2. PBYI vs ELLO Comparison

PBYI vs ELLO Comparison

Compare PBYI & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$7.57

Market Cap

343.9M

Sector

Health Care

ML Signal

HOLD

ELLO

Ellomay Capital Ltd (Israel)

HOLD

Current Price

$24.37

Market Cap

352.8M

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBYI
ELLO
Founded
2010
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
343.9M
352.8M
IPO Year
2011
1998

Fundamental Metrics

Financial Performance
Metric
PBYI
ELLO
Price
$7.57
$24.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
257.8K
3.2K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$27,685,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.75
$13.21
52 Week High
$7.90
$30.34

Technical Indicators

Market Signals
Indicator
PBYI
ELLO
Relative Strength Index (RSI) 67.52 42.57
Support Level $5.75 $23.41
Resistance Level N/A $25.70
Average True Range (ATR) 0.33 0.51
MACD 0.14 -0.04
Stochastic Oscillator 82.18 12.29

Price Performance

Historical Comparison
PBYI
ELLO

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About ELLO Ellomay Capital Ltd (Israel)

Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.

Share on Social Networks: